Which patients with relapsed non-Hodgkin's lymphoma benefit from high- dose therapy and hematopoietic stem-cell transplantation?
AS Freedman and LM Nadler
JCO Oct 1 1993: 1841–1843. [PDF]
Photodynamic therapy: shining light where it is needed
E Glatstein and DI Rosenthal
JCO Oct 1 1993: 1844–1845. [PDF]
	High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphoma
	JM Vose, JR Anderson, A Kessinger, PJ Bierman, P Coccia, EC Reed, B Gordon, and JO Armitage
	JCO Oct 1 1993: 1846–1851. [Abstract] [PDF]
	A prospective phase II study on photodynamic therapy with photofrin II for centrally located early-stage lung cancer. The Japan Lung Cancer Photodynamic Therapy Study Group
	K Furuse, M Fukuoka, H Kato, T Horai, K Kubota, N Kodama, Y Kusunoki, N Takifuji, T Okunaka, and C Konaka
	JCO Oct 1 1993: 1852–1857. [Abstract] [PDF]
	Multiple-drug weekly chemotherapy versus standard combination regimen in small-cell lung cancer: a phase III randomized study conducted by the European Lung Cancer Working Party
	JP Sculier, M Paesmans, G Bureau, G Dabouis, P Libert, G Vandermoten, O Van Cutsem, MC Berchier, F Ries, and J Michel
	JCO Oct 1 1993: 1858–1865. [Abstract] [PDF]
	Chemotherapy for advanced non-small-cell lung cancer: how much benefit is enough?
	R Grilli, AD Oxman, and JA Julian
	JCO Oct 1 1993: 1866–1872. [Abstract] [PDF]
	Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer
	O Dassonville, JL Formento, M Francoual, A Ramaioli, J Santini, M Schneider, F Demard, and G Milano
	JCO Oct 1 1993: 1873–1878. [Abstract] [PDF]
	The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03
	N Wolmark, H Rockette, B Fisher, DL Wickerham, C Redmond, ER Fisher, J Jones, EP Mamounas, L Ore, and NJ Petrelli
	JCO Oct 1 1993: 1879–1887. [Abstract] [PDF]
	A randomized, double-blind trial of fluorouracil plus placebo versus fluorouracil plus oral leucovorin in patients with metastatic colorectal cancer
	LR Laufman, RM Bukowski, MA Collier, BA Sullivan, RA McKinnis, NJ Clendennin, A Guaspari, and WD Brenckman, Jr
	JCO Oct 1 1993: 1888–1893. [Abstract] [PDF]
	Comparison of the prognostic significance between the number of metastatic lymph nodes and nodal stage based on their location in patients with gastric cancer
	T Ichikura, S Tomimatsu, Y Okusa, K Uefuji, and S Tamakuma
	JCO Oct 1 1993: 1894–1900. [Abstract] [PDF]
	Tumor-cell DNA content predicts outcome in children and adolescents with clinical group III embryonal rhabdomyosarcoma. The Intergroup Rhabdomyosarcoma Study Committee of the Children's Cancer Group and the Pediatric Oncology Group [published erratum appears in J Clin Oncol 1994 Feb;12(2):440]
	AS Pappo, WM Crist, J Kuttesch, S Rowe, RA Ashmun, HM Maurer, WA Newton, L Asmar, X Luo, and DN Shapiro
	JCO Oct 1 1993: 1901–1905. [Abstract] [PDF]
	Corrected QT interval prolongation in anthracycline-treated survivors of childhood cancer
	CL Schwartz, WL Hobbie, S Truesdell, LC Constine, and EB Clark
	JCO Oct 1 1993: 1906–1910. [Abstract] [PDF]
	Total-body irradiation and autologous bone marrow transplant in the treatment of high-risk Ewing's sarcoma and rhabdomyosarcoma
	ME Horowitz, TJ Kinsella, LH Wexler, J Belasco, T Triche, M Tsokos, SM Steinberg, L McClure, DL Longo, and RG Steis
	JCO Oct 1 1993: 1911–1918. [Abstract] [PDF]
	Effectiveness of combined induction chemotherapy and radiotherapy in advanced nasopharyngeal carcinoma
	IW Dimery, LJ Peters, H Goepfert, WH Morrison, RM Byers, C Guillory, K McCarthy, RS Weber, and WK Hong
	JCO Oct 1 1993: 1919–1928. [Abstract] [PDF]
	Tumor necrosis is a prognostic predictor for early recurrence and death in lymph node-positive breast cancer: a 10-year follow-up study of 728 Eastern Cooperative Oncology Group patients
	KW Gilchrist, R Gray, B Fowble, DC Tormey, and SG Taylor, 4th
	JCO Oct 1 1993: 1929–1935. [Abstract] [PDF]
	Clinical significance of HER-2/neu oncogene amplification in primary breast cancer. The South Australian Breast Cancer Study Group
	R Seshadri, FA Firgaira, DJ Horsfall, K McCaul, V Setlur, and P Kitchen
	JCO Oct 1 1993: 1936–1942. [Abstract] [PDF]
	Paclitaxel and recombinant human granulocyte colony-stimulating factor as initial chemotherapy for metastatic breast cancer
	BS Reichman, AD Seidman, JP Crown, R Heelan, TB Hakes, DE Lebwohl, TA Gilewski, A Surbone, V Currie, and CA Hudis
	JCO Oct 1 1993: 1943–1951. [Abstract] [PDF]
	Carboplatin plus ifosfamide as salvage treatment of epithelial ovarian cancer: a pilot study
	V Lorusso, A Catino, B Leone, M Rabinovich, G Gargano, A Paradiso, and M De Lena
	JCO Oct 1 1993: 1952–1956. [Abstract] [PDF]
	Hormonal palliation of chemoresistant ovarian cancer: three consecutive phase II trials of the Mid-Atlantic Oncology Program
	JD Ahlgren, NM Ellison, RJ Gottlieb, F Laluna, JJ Lokich, PR Sinclair, W Ueno, GL Wampler, KY Yeung, and D Alt
	JCO Oct 1 1993: 1957–1968. [Abstract] [PDF]
	Randomized phase III trial of treatment with high-dose interleukin-2 either alone or in combination with interferon alfa-2a in patients with advanced melanoma
	JA Sparano, RI Fisher, M Sunderland, K Margolin, ML Ernest, M Sznol, MB Atkins, JP Dutcher, KC Micetich, and GR Weiss
	JCO Oct 1 1993: 1969–1977. [Abstract] [PDF]
	Involved-field radiotherapy and intra-Ommaya methotrexate/cytarabine in patients with AIDS-related lymphomatous meningitis
	MC Chamberlain and L Dirr
	JCO Oct 1 1993: 1978–1984. [Abstract] [PDF]
	Richter's syndrome: a report on 39 patients
	LE Robertson, W Pugh, S O'Brien, H Kantarjian, C Hirsch-Ginsberg, A Cork, P McLaughlin, F Cabanillas, and MJ Keating
	JCO Oct 1 1993: 1985–1989. [Abstract] [PDF]
	Adult acute lymphoblastic leukemia: a multicentric randomized trial testing bone marrow transplantation as postremission therapy. The French Group on Therapy for Adult Acute Lymphoblastic Leukemia
	D Fiere, E Lepage, C Sebban, C Boucheix, C Gisselbrecht, JP Vernant, B Varet, A Broustet, JY Cahn, and F Rigal-Huguet
	JCO Oct 1 1993: 1990–2001. [Abstract] [PDF]
	Phase I clinical and pharmacokinetic evaluation of high-dose mitoxantrone in combination with cytarabine in patients with acute leukemia
	EJ Feldman, DS Alberts, Z Arlin, T Ahmed, A Mittelman, P Baskind, YM Peng, M Baier, and P Plezia
	JCO Oct 1 1993: 2002–2009. [Abstract] [PDF]
	Phase I and pharmacologic study of paclitaxel and cisplatin with granulocyte colony-stimulating factor: neuromuscular toxicity is dose- limiting
	EK Rowinsky, V Chaudhry, AA Forastiere, SE Sartorius, DS Ettinger, LB Grochow, BG Lubejko, DR Cornblath, and RC Donehower
	JCO Oct 1 1993: 2010–2020. [Abstract] [PDF]
	Phase I dose-escalation trial of iodine 131-labeled monoclonal antibody OKB7 in patients with non-Hodgkin's lymphoma
	MS Czuczman, DJ Straus, CR Divgi, M Graham, P Garin-Chesa, R Finn, J Myers, LJ Old, SM Larson, and DA Scheinberg
	JCO Oct 1 1993: 2021–2029. [Abstract] [PDF]
	Phase I study of CPT-11 and etoposide in patients with refractory solid tumors
	A Karato, Y Sasaki, T Shinkai, K Eguchi, T Tamura, Y Ohe, F Oshita, M Nishio, H Kunikane, and H Arioka
	JCO Oct 1 1993: 2030–2035. [Abstract] [PDF]
	Five-year administration of fenretinide: pharmacokinetics and effects on plasma retinol concentrations
	F Formelli, M Clerici, T Campa, MG Di Mauro, A Magni, G Mascotti, D Moglia, G De Palo, A Costa, and U Veronesi
	JCO Oct 1 1993: 2036–2042. [Abstract] [PDF]
	Effect of dietary counseling on food intake, body weight, response rate, survival, and quality of life in cancer patients undergoing chemotherapy: a prospective, randomized study
	L Ovesen, L Allingstrup, J Hannibal, EL Mortensen, and OP Hansen
	JCO Oct 1 1993: 2043–2049. [Abstract] [PDF]
Prognostic value of performance status and quality-of-life scores during chemotherapy for advanced breast cancer. The Australian New Zealand Breast Cancer Trials Group
A Coates, J Forbes, and RJ Simes
JCO Oct 1 1993: 2050a. [PDF]
Secondary cytoreduction: can it be justified?
NP O'Rourke and HE Lambert
JCO Oct 1 1993: 2050b–2051. [PDF]
Postchemotherapy rheumatism: is this a menopausal symptom?
JE Siegel
JCO Oct 1 1993: 2051a. [PDF]
More postchemotherapy rheumatism
I Michl and CC Zielinski
JCO Oct 1 1993: 2051b–2052. [PDF]
Hepatic artery chemotherapy for colorectal liver metastases: yet more controversy
PD Schneider
JCO Oct 1 1993: 2052–2054. [PDF]
Splenectomy and risk of secondary leukemia
AT Meadows and L Robison
JCO Oct 1 1993: 2054a. [PDF]
Ten years' experience with LSA2-L2 therapy for childhood advanced lymphoblastic lymphoma
JA Katz, E Hvizdala, J Shuster, JM Falletta, M Schwenn, and SB Murphy
JCO Oct 1 1993: 2054b–2055. [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.